AnaCardio

Business Data, Corporate Office and Headquarter Address

About

AnaCardio is Drug Discovery in Sweden that focus on developer business. They cover business area such as developer, drug, cardiac contractility, clinical outcome, heart failure, Stealth mode.

Business Type

Drug Discovery

Country

Sweden

Founded

-

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

Solna
Sweden

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerdrugcardiac contractilityclinical outcomeheart failureStealth mode

* We use standard office opening hours in near AnaCardio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

AnaCardio Frequently Asked Questions

What or who is AnaCardio?

AnaCardio is Drug Discovery business from Sweden that founded in - ( years old in ), AnaCardio business is focusing on Developer.

Where is AnaCardio headquarter and corporate office address?

AnaCardio headquarter office and corporate office address is located in Solna Sweden.

Where is AnaCardio country origins?

AnaCardio was founded in Sweden.

What is Developer business focus on?

In , AnaCardio is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with AnaCardio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.